Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.
Lender and Broker Services, Products, and Software “What would 50-100 bps more per jumbo loan mean for your team? Winning in ...
Here's a closer look at what Rossi brings to the table, including both the strengths and question marks of his game.
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived ...
Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.
NIS2 is in effect and the to-do list for CISOs is exploding. The frequent result: unclear requirements, a huge documentation ...
StockStory.org on MSN
The Top 5 Analyst Questions From Jabil’s Q4 Earnings Call
Jabil’s fourth quarter delivered results that met Wall Street’s expectations, with strength attributed to robust demand in its Intelligent Infrastructure segment and steady contributions from ...
Project supports AI designed to understand what people see, remember, and describe. Chicago, Illinois–(Newsfile Corp. – December 24, 2025) – Global outsourcing company Hugo delivered nearly 3 ...
A team of Sweden-based researchers has developed a snow loss model to estimate snow-induced PV power losses on an hourly basis. The proposed approach relies solely on data from remote sensing sources, ...
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...
Cash flow isn’t just about what’s sitting in the bank today; it’s about visibility into what’s coming next. And that starts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results